|
Voriconazole EP Impurity B
|
伏立康唑EP雜質(zhì)B
|
182369-73-9
|
|
Levocetirizine Impurity 20
|
左西替利嗪雜質(zhì)20
|
1243652-36-9
|
|
Erythromycin A 9-Oxime
|
阿奇霉素雜質(zhì)S
|
13127-18-9
|
|
Tedizolid Impurity 4
|
特地唑胺雜質(zhì)8
|
1256966-02-5
|
|
Vonoprazan Impurity 37
|
沃諾拉贊雜質(zhì)7
|
1610043-62-3
|
|
N-(2-chloro-5-(trifluoromethyl)phenyl)pivalamide
|
標(biāo)準(zhǔn)品RN1055
|
13691-96-8
|
|
1，4-dinitrosopiperazine
|
標(biāo)準(zhǔn)品RN1031
|
140-79-4
|
|
Torasemide EP Impurity D
|
托拉塞米EP雜質(zhì)D
|
160972-33-8
|
|
Terazosin EP Impurity F
|
特拉唑嗪EP雜質(zhì)F
|
109678-71-9
|
|
4-Hydroxy Lidocaine
|
4-羥基利多卡因
|
39942-41-1
|
|
Aripiprazole Impurity 1
|
阿立哌唑雜質(zhì)28
|
519138-48-8
|
|
Medetomidine Impurity 1
|
美托咪定雜質(zhì)56
|
2250243-24-2
|
|
2-Methyl-3-(trifluoromethyl)pivalanilide
|
標(biāo)準(zhǔn)品RN1054
|
150783-50-9
|
|
Tofacitinib Impurity 2
|
托法替尼雜質(zhì)2
|
2174011-55-1
|
|
Tenofovir Impurity 26
|
替諾福韋雜質(zhì)17
|
1884329-63-8
|
|
Terbutaline Impurity 5
|
特布他林雜質(zhì)3
|
30923-82-1
|
|
Telmisartan EP Impurity C
|
替米沙坦EP雜質(zhì)C
|
144702-26-1
|
|
Telmisartan EP Impurity F
|
替米沙坦EP雜質(zhì)F
|
915124-86-6
|
|
Terazosin EP Impurity H
|
特拉唑嗪EP雜質(zhì)H
|
105356-90-9
|
|
Vortioxetine Impurity 20
|
沃替西汀雜質(zhì)13
|
1639263-80-1
|
|
Valsartan Impurity 3
|
纈沙坦雜質(zhì)7
|
914465-68-2
|
|
Vonoprazan Impurity 2
|
沃諾拉贊雜質(zhì)27
|
928325-68-2
|
|
Vildagliptin Impurity 1
|
維格列汀雜質(zhì)18
|
243145-00-8
|
|
Tenofovir Impurity 12
|
替諾福韋雜質(zhì)58
|
1244022-52-3
|
|
Tipiracil Impurity 1
|
尿嘧啶雜質(zhì)1
|
22126-44-9
|
|
Tofacitinib Impurity 7
|
托法替尼雜質(zhì)36
|
2227199-31-5
|
|
Trifluridine Impurity 2
|
曲氟尿苷雜質(zhì)2
|
7057-42-3
|
|
Telmisartan EP Impurity G
|
替米沙坦EP雜質(zhì)G
|
144702-27-2
|
|
Trimetazidine EP Impurity A
|
曲美他嗪EP雜質(zhì)A
|
52146-35-7
|
|
Doxazosin Impurity 2
|
特拉唑嗪雜質(zhì)2
|
60547-96-8
|
|
Torasemide EP Impurity E
|
托拉塞米EP雜質(zhì)E
|
72810-57-2
|
|
Telmisartan EP Impurity B
|
替米沙坦EP雜質(zhì)B
|
1026353-20-7
|
|
1-(1-ethylpyrrolidin-2-yl)-N-methylmethanamine
|
標(biāo)準(zhǔn)品RN1033
|
60923-27-5
|
|
Tedizolid Impurity 2
|
特地唑胺雜質(zhì)6
|
1239662-48-6
|
|
Vonoprazan Impurity 35
|
沃諾拉贊雜質(zhì)1
|
881732-90-7
|
|
Tenofovir Impurity 8
|
替諾福韋雜質(zhì)64
|
161760-03-8
|
|
Medetomidine Impurity 17
|
美托咪定雜質(zhì)58
|
2514763-84-7
|
|
Terazosin EP Impurity D
|
特拉唑嗪EP雜質(zhì)D
|
102714-74-9
|
|
Vonoprazan Impurity 39
|
沃諾拉贊雜質(zhì)19
|
1224739-02-9
|
|
(1，3-dichloropropyl)benzene
|
標(biāo)準(zhǔn)品RN1040
|
14155-36-3
|
|
Medetomidine Impurity 7
|
美托咪定雜質(zhì)57
|
145108-58-3
|
|
Vildagliptin Impurity 3
|
維格列汀雜質(zhì)4
|
6708-06-1
|
|
Tofacitinib Impurity 20
|
托法替尼雜質(zhì)11
|
1675248-19-7
|
|
Valsartan Impurity 4
|
纈沙坦雜質(zhì)1
|
676129-92-3
|
|
Terazosin EP Impurity I
|
特拉唑嗪EP雜質(zhì)I
|
1177261-85-6
|
|
Cefditoren Pivoxi Impurity 7
|
頭孢妥侖匹酯雜質(zhì)7
|
878002-84-7
|
|
Tedizolid Impurity 1
|
特地唑胺雜質(zhì)7
|
1239662-47-5
|
|
Tranexamic Acid EP Impurity C HCl
|
氨甲環(huán)酸EP雜質(zhì)C HCl
|
1803601-44-6
|
|
Tedizolid Impurity 10
|
特地唑胺雜質(zhì)22
|
2044712-34-5
|
|
Thioctic Acid Impurity 1
|
硫辛酸雜質(zhì)6
|
1070-65-1
|
|
Voriconazole Impurity 1
|
伏立康唑雜質(zhì)12
|
182230-43-9
|
|
Voriconazole Impurity 2
|
伏立康唑雜質(zhì)21
|
137234-75-4
|
|
Tedizolid Impurity 16
|
特地唑胺雜質(zhì)28
|
380380-63-2
|
|
Tartrazine Impurity 1
|
檸檬黃雜質(zhì)3
|
56120-28-6
|
|
Levocetirizine Impurity 24
|
左西替利嗪雜質(zhì)24
|
83881-46-3
|
|
Thioctic Acid Impurity 4
|
硫辛酸雜質(zhì)9
|
17370-41-1
|
|
Tenofovir Impurity 24
|
替諾福韋雜質(zhì)42
|
1796545-19-1
|
|
Ticagrelor Impurity 1
|
替格瑞洛雜質(zhì)21
|
1644461-81-3
|
|
Terazosin Impurity 1
|
特拉唑嗪雜質(zhì)1
|
134749-43-2
|
|
Medetomidine Impurity 26
|
美托咪定雜質(zhì)59
|
27831-13-6
|
|
Tenofovir Impurity 11
|
二乙基替諾福韋
|
180587-75-1
|
|
Tartrazine Impurity 3
|
檸檬黃雜質(zhì)9
|
17596-06-4
|
|
Terazosin EP Impurity J
|
特拉唑嗪EP雜質(zhì)J
|
152551-75-2
|
|
Cefditoren Pivoxi Impurity 3
|
頭孢妥侖匹酯雜質(zhì)3
|
138514-32-6
|
|
Vildagliptin Impurity 4
|
維格列汀雜質(zhì)26
|
19943-27-2
|
|
Tenofovir Impurity 9
|
替諾福韋雜質(zhì)65
|
161760-09-4
|
|
Tedizolid Impurity 17
|
特地唑胺雜質(zhì)26
|
1252686-47-7
|
|
Chlorphenamine Impurity 1
|
氯苯那敏氮氧化物
|
120244-82-8
|
|
Tofacitinib Impurity 5
|
托法替尼雜質(zhì)19
|
2227197-38-6
|
|
USP Trifluridine Related Compound A
|
曲氟尿苷雜質(zhì)1
|
14599-46-3
|
|
Vortioxetine Impurity 21
|
N-乙酰沃替西汀
|
1801352-86-2
|
|
Valproic Acid EP Impurity I
|
丙戊酸EP雜質(zhì)I
|
13310-75-3
|
|
Tartrazine Impurity 2
|
檸檬黃雜質(zhì)8
|
76-30-2
|
|
(S，S)-Formoterol
|
(S,S)-福莫特羅
|
67346-48-9
|
|
N-Formyl Trimetazidine HCl
|
N-甲酰曲美他嗪鹽酸鹽
|
879646-17-0
|
|
Tofacitinib Impurity 8
|
托法替尼雜質(zhì)21
|
1640971-60-3
|
|
Tofacitinib Impurity 14
|
托法替尼雜質(zhì)7
|
344418-92-4
|
|
Telmisartan Ethyl Ester
|
替米沙坦雜質(zhì)16
|
528560-94-3
|
|
Terazosin EP Impurity G
|
特拉唑嗪EP雜質(zhì)G
|
105356-89-6
|
|
Tedizolid Impurity 5
|
特地唑胺雜質(zhì)17
|
2095200-69-2
|
|
Ticagrelor Impurity 4
|
替格瑞洛雜質(zhì)3
|
2165799-36-8
|
|
Fusidic Acid EP Impurity G（ Sodium Fusidate EP Impurity G）
|
夫西地酸EP雜質(zhì)G
|
4680-37-9
|
|
Voriconazole EP Impurity D
|
伏立康唑EP雜質(zhì)D
|
137234-63-0
|
|
Norfloxacin EP Impurity B
|
諾氟沙星EP雜質(zhì)B
|
75001-77-3
|
|
Tenofovir Impurity 5
|
替諾福韋雜質(zhì)50
|
851456-00-3
|
|
Valsartan Impurity 1
|
纈沙坦雜質(zhì)2
|
1111177-24-2
|
|
Debenzoic Acid Bromo Telmisartan
|
替米沙坦雜質(zhì)8
|
1004548-55-3
|
|
Desonide USP Impurity G
|
地奈德USP雜質(zhì)G
|
39672-77-0
|
|
Moxifloxacin impurity 13
|
莫西沙星雜質(zhì)61
|
121577-35-3
|
|
Telmisartan EP Impurity J
|
替米沙坦雜質(zhì)17
|
885045-90-9
|
|
Tranexamic Acid EP Impurity E
|
氨甲環(huán)酸EP雜質(zhì)E
|
82755-59-7
|
|
Valsartan Impurity 2
|
纈沙坦雜質(zhì)11
|
137863-90-2
|
|
Gadobutrol Impurity 6
|
釓布醇雜質(zhì)6
|
112193-75-6
|
|
Cefditoren Pivoxi Impurity 2
|
Δ3-頭孢妥侖匹酯
|
148774-47-4
|
|
Torasemide Impurity 1
|
托拉塞米雜質(zhì)7
|
947327-54-0
|
|
Tofacitinib Impurity 11
|
托法替尼雜質(zhì)23
|
1640972-35-5
|
|
Moxifloxacin impurity 19
|
莫西沙星雜質(zhì)62
|
929962-29-8
|
|
Tofacitinib Impurity 18
|
托法替尼雜質(zhì)27
|
2459302-85-1
|
|
Valproic Acid EP Impurity G
|
丙戊酸EP雜質(zhì)G
|
52061-73-1
|
|
Tranexamic Acid EP Impurity A
|
氨甲環(huán)酸EP雜質(zhì)A
|
93940-19-3
|